Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 1, 2011, Pages 224-225

  Calcagno, A ^a   Baietto, L ^a   De Rosa, F G ^a   Tettoni, M C ^a   Libanore, V ^a   Bertucci, R ^a   D'Avolio, A ^a   Di perri, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Antifungals; CSF penetration; Darunavir; Interactions

Indexed keywords

ABACAVIR; AMPHOTERICIN B LIPID COMPLEX; ATOVAQUONE; AZITHROMYCIN; DARUNAVIR; LAMIVUDINE; PANTOPRAZOLE; POSACONAZOLE; PYRIMETHAMINE SULFADIAZINE; RITONAVIR;

BRAIN BIOPSY; BRAIN INFECTION; BRAIN MUCORMYCOSIS; CD4 CD8 RATIO; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MUCORALES; NONHUMAN; SIDE EFFECT; STOMACH DISEASE;

AFRICA, WESTERN; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; BRAIN; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CEREBROSPINAL FLUID; HIV INFECTIONS; HUMANS; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE IMAGING; MUCORMYCOSIS; TRIAZOLES;

EID: 78650401406     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq385     Document Type: Letter

References (7)

1. Sun QN, Fothergill AW, McCarthy DI et al. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 2002; 46: 1581-2.
2. Ruping MJ, Albermann N, Ebinger F et al. Posaconazole concentrations in the central nervous system. J Antimicrob Chemother 2008; 62: 1468-70.
3. Reinwald M, Uharek L, Lampe D et al. Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis. Bone Marrow Transplant 2009; 44: 269-70.
4. D'Avolio A, Baietto L, Siccardi M et al. An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients. Ther Drug Monit 2008; 30: 662-9.
5. Alffenaar JC, van Assen S, van der Werf TS et al. Omeprazole significantly reduces posaconazole serum trough level. Clin Infect Dis 2009; 48: 839.
6. Ullmann AJ, Cornely OA, Burchardt A et al. Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother 2006; 50: 658-66.
7. Yilmaz A, Izadkhashti A, Price RW et al. Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals. AIDS Res Hum Retroviruses 2009; 25: 457-61.